74852 Comparing CDKN2A Germline Mutation Carriers and Germline-Negative Patients with Melanoma
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB120
DOI: 10.1016/j.jaad.2026.04.490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Sarah Amjad und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Amjad, S., Breinholt, J., Starghill, M., Ho, A., & Costello, C. M. (2026). 74852 Comparing CDKN2A Germline Mutation Carriers and Germline-Negative Patients with Melanoma. Journal of the American Academy of Dermatology, 95(1), AB120. https://doi.org/10.1016/j.jaad.2026.04.490
Vancouver
Amjad S, Breinholt J, Starghill M, Ho A, Costello CM. 74852 Comparing CDKN2A Germline Mutation Carriers and Germline-Negative Patients with Melanoma. Journal of the American Academy of Dermatology. 2026;95(1):AB120. doi:10.1016/j.jaad.2026.04.490
BibTeX
@article{Amjad2026,
author = {Amjad, Sarah and Breinholt, Jacob and Starghill, Micah and Ho, Andy and Costello, Collin M.},
title = {74852 Comparing CDKN2A Germline Mutation Carriers and Germline-Negative Patients with Melanoma},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB120},
doi = {10.1016/j.jaad.2026.04.490}
}
EUVIMED